Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambr Nutri Sci Regulatory News (CNSL)

Share Price Information for Cambr Nutri Sci (CNSL)

Share Price is delayed by 15 minutes
Get Live Data
1.75    0.00 (0.00%)
Bid:
1.60
Ask:
1.90
Spread: 0.30 (18.75%)
Market Cap: £4.16m
CNSL Live PriceLast checked at - London Stock Exchange

Intraday Cambr Nutri Sci Share Chart

Resolution on HSE Matter

23 May 2025 07:00

RNS Number : 8821J
Cambridge Nutritional Sciences PLC
23 May 2025
 

 

Cambridge Nutritional Sciences plc

 

(the "Company" or "CNSL")

 

Resolution on HSE Matter

 

Cambridge Nutritional Sciences plc (AIM:CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 22 May 2025 sentencing occurred in respect of legal proceedings brought against its wholly-owned subsidiary Omega Diagnostics Limited by the Health & Safety Executive, in relation to four historical breaches of health and safety regulations in 2018. The breaches relate to Omega South West, a company previously owned by Omega Diagnostics Limited. Omega South West was sold in 2018 and therefore is no longer a trading entity of the Company.

 

In March 2025, Omega Diagnostics entered guilty pleas in respect of the four identified breaches. At yesterday's sentencing hearing the court found that there was no deliberate breach or flagrant disregard for the law, found no aggravating factors, and found substantial mitigating factors including: no previous convictions, good health and safety record, full cooperation, sincere regret expressed, and breaches over only a narrow window of time. The court also gave full credit for early guilty pleas. The court imposed a total fine of £0.035m in respect of all charges.

 

With this outcome, the matter is now formally concluded with no further liability or legal action expected in relation to this case.

 

The financial impact of the fine has been fully provided for within the Group's existing provisions. As such, there will be no material effect on the Company's financial performance for the current or future financial years. The outcome will be appropriately disclosed in the Group's forthcoming Annual Report and Financial Statements.

 

The Board reaffirms its commitment to upholding the highest standards of compliance and corporate responsibility across all of its operations.

 

Following the conclusion of this matter, the Company intends to make a trading update for the year ended 31 March 2025 shortly.

 

 

 

 

Contacts: 

Cambridge Nutritional Sciences plc

www.cnsplc.com

Carolyn Rand, Non-Executive Chair

investors@cnsplc.com 

James Cooper, Chief Executive Officer

Cavendish Capital Markets Limited

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / (Corporate Finance)

Nigel Birks / Harriet Ward (ECM)

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFIFESIFFIE
12
Date   Source Headline
22nd Apr 20267:00 amRNSTrading & Business Update
31st Mar 20265:35 pmRNSHolding(s) in Company
31st Mar 20265:32 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSHalf-year Report
4th Nov 20257:00 amRNSNotice of Results & Investor Presentation
25th Sep 20254:30 pmRNSResult of AGM
28th Aug 20257:00 amRNSNotice of AGM & Annual Report
21st Aug 20257:00 amRNSGrant of Options
19th Aug 20257:00 amRNSFinal Results
31st Jul 20257:00 amRNSNotice of Results & Investor Presentation
10th Jul 20257:00 amRNSDirectorate Change
2nd Jul 20257:00 amRNSHolding(s) in Company
27th May 20257:00 amRNSTrading Update
23rd May 20257:00 amRNSResolution on HSE Matter
8th Apr 20257:00 amRNSGrant of Options
1st Apr 20257:00 amRNSAppointment of Chief Executive Officer
21st Mar 202511:33 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSOmega Diagnostics Summons Update
18th Mar 20252:48 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSDirector/PDMR Shareholding
30th Jan 20259:41 amRNSDirector/PDMR Shareholding
21st Jan 20254:03 pmRNSOmega Diagnostics court summons
16th Jan 20257:00 amRNSSettlement of DHSC Claim
7th Jan 20255:25 pmRNSHolding(s) in Company
7th Jan 20255:20 pmRNSHolding(s) in Company
4th Dec 20241:33 pmRNSHolding(s) in Company
4th Dec 20241:32 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSHalf-year Report
15th Nov 20249:24 amRNSNotice of Results and Investor Presentation
27th Sep 202411:20 amRNSResult of AGM
15th Aug 20243:44 pmRNSPosting of Annual Report and Notice of AGM
13th Aug 20247:00 amRNSDirectorate Change
5th Aug 202410:29 amRNSGrant of Options
25th Jul 20247:00 amRNSFinal Results
10th Jul 20247:00 amRNSNotice of Results
6th Jun 20244:26 pmRNSGrant of Options
24th May 20247:00 amRNSDirectorate Change
22nd Apr 20248:21 amRNSTrading Update and Directorate Change
3rd Apr 20247:00 amRNSQ2 2024 Industry Events Schedule
30th Jan 202412:50 pmRNSIssue of Equity and Total Voting Rights
29th Jan 20247:00 amRNSAppointment of Operations Director
22nd Jan 20247:00 amRNSScientific Educational Webinar and Industry Event
18th Dec 20233:51 pmRNSHolding(s) in Company
4th Dec 20237:00 amRNSScientific Educational Programme expanded
28th Nov 20233:56 pmRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
22nd Nov 202310:59 amRNSHolding(s) in Company
20th Nov 202311:09 amRNSHolding(s) in Company
17th Nov 202312:55 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.